396 related articles for article (PubMed ID: 33535566)
1. The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.
Qaddumi WN; Jose PA
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535566
[TBL] [Abstract][Full Text] [Related]
2. Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.
Yang J; Villar VAM; Jose PA; Zeng C
Antioxid Redox Signal; 2021 Mar; 34(9):716-735. PubMed ID: 32349533
[No Abstract] [Full Text] [Related]
3. Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.
Yang S; Yang Y; Yu P; Yang J; Jiang X; Villar VA; Sibley DR; Jose PA; Zeng C
Free Radic Res; 2015 Apr; 49(4):397-410. PubMed ID: 25740199
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of renal dopamine D1 receptor function during oxidative stress.
Banday AA; Lokhandwala MF
Hypertension; 2015 May; 65(5):1064-72. PubMed ID: 25733244
[TBL] [Abstract][Full Text] [Related]
5. Renal dopamine receptors, oxidative stress, and hypertension.
Cuevas S; Villar VA; Jose PA; Armando I
Int J Mol Sci; 2013 Aug; 14(9):17553-72. PubMed ID: 23985827
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats.
Banday AA; Lau YS; Lokhandwala MF
Hypertension; 2008 Feb; 51(2):367-75. PubMed ID: 18158345
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.
Wang X; Escano CS; Asico L; Jones JE; Barte A; Lau YS; Jose PA; Armando I
Hypertension; 2013 Aug; 62(2):295-301. PubMed ID: 23753418
[TBL] [Abstract][Full Text] [Related]
8. Role of dopamine in the pathogenesis of hypertension.
Jose PA; Eisner GM; Felder RA
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
[TBL] [Abstract][Full Text] [Related]
9. In Utero Exposure to Fine Particulate Matter Causes Hypertension Due to Impaired Renal Dopamine D1 Receptor in Offspring.
Ye Z; Lu X; Deng Y; Wang X; Zheng S; Ren H; Zhang M; Chen T; Jose PA; Yang J; Zeng C
Cell Physiol Biochem; 2018; 46(1):148-159. PubMed ID: 29614490
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of etamicastat in dopamine D2 receptor-deficient mice.
Armando I; Asico LD; Wang X; Jones JE; Serrão MP; Cuevas S; Grandy DK; Soares-da-Silva P; Jose PA
Hypertens Res; 2018 Jul; 41(7):489-498. PubMed ID: 29654295
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin-4 and Dopamine D5 Receptor Interact to Reduce Oxidative Stress and Inflammation in the Kidney.
Amatya B; Yang S; Yu P; Vaz de Castro PAS; Armando I; Zeng C; Felder RA; Asico LD; Jose PA; Lee H
Antioxid Redox Signal; 2023 Jun; 38(16-18):1150-1166. PubMed ID: 36401517
[No Abstract] [Full Text] [Related]
12. The Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.
Jiang X; Chen W; Liu X; Wang Z; Liu Y; Felder RA; Gildea JJ; Jose PA; Qin C; Yang Z
PLoS One; 2016; 11(1):e0146641. PubMed ID: 26751218
[TBL] [Abstract][Full Text] [Related]
13. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
Cuevas S; Yang Y; Konkalmatt P; Asico LD; Feranil J; Jones J; Villar VA; Armando I; Jose PA
Hypertension; 2015 Jun; 65(6):1251-7. PubMed ID: 25895590
[TBL] [Abstract][Full Text] [Related]
14. Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.
Gildea JJ
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):28-32. PubMed ID: 19077686
[TBL] [Abstract][Full Text] [Related]
15. The dopaminergic system in hypertension.
Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
[TBL] [Abstract][Full Text] [Related]
16. Renal Dopamine Oxidation and Inflammation in High Salt Fed Rats.
Banday AA; Lokhandwala MF
J Am Heart Assoc; 2020 Jan; 9(1):e014977. PubMed ID: 31880979
[TBL] [Abstract][Full Text] [Related]
17. The dopaminergic system in hypertension.
Amenta F; Ricci A; Rossodivita I; Avola R; Tayebati SK
Clin Exp Hypertens; 2001; 23(1-2):15-24. PubMed ID: 11270582
[TBL] [Abstract][Full Text] [Related]
18. Renal dopaminergic system: Pathophysiological implications and clinical perspectives.
Choi MR; Kouyoumdzian NM; Rukavina Mikusic NL; Kravetz MC; Rosón MI; Rodríguez Fermepin M; Fernández BE
World J Nephrol; 2015 May; 4(2):196-212. PubMed ID: 25949933
[TBL] [Abstract][Full Text] [Related]
19. Renal dopamine receptors in health and hypertension.
Jose PA; Eisner GM; Felder RA
Pharmacol Ther; 1998 Nov; 80(2):149-82. PubMed ID: 9839770
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors in hypertension.
Bek MJ; Eisner GM; Felder RA; Jose PA
Mt Sinai J Med; 2001 Nov; 68(6):362-9. PubMed ID: 11687863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
